TICKERNOMICS Sign up
Last Update: 2024-03-28 02:15:49
BIMI International Medical Inc. ( BIMI ) https://www.usbimi.com/index.html
1.98USD
Sector:
Healthcare
Industry:
Pharmaceutical Retailers
Country:
China
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
BIMI
260.00%
SPY
32.74%
-97.72%
BIMI
SPY
92.93%
-99.36%
BIMI
SPY
224.41%
-97.61%
BIMI
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
8.46
8.57
0.02
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.41
33.54
0.68
-94.45
0.00
-2.63
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
23.38
51.89
-29.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
14.8632
28.39
37.64
2.84
Other Earnings and Cash Flow Stats:
BIMI International Medical Inc. ( BIMI ) Net Income TTM ($MM) is -25.48
BIMI International Medical Inc. ( BIMI ) Operating Income TTM ($MM) is -11.23
BIMI International Medical Inc. ( BIMI ) Owners' Earnings Annual ($MM) is -13.00
BIMI International Medical Inc. ( BIMI ) Current Price to Owners' Earnings ratio is -0.70
BIMI International Medical Inc. ( BIMI ) EBITDA TTM ($MM) is -12.10
BIMI International Medical Inc. ( BIMI ) EBITDA Margin is -29.00%
Capital Allocation:
BIMI International Medical Inc. ( BIMI ) has paid 0.00 dividends per share and bought back -1.931787 million shares in the past 12 months
BIMI International Medical Inc. ( BIMI ) has reduced its debt by 5.974237 million USD in the last 12 months
Capital Structure:
BIMI International Medical Inc. ( BIMI ) Interest-bearing Debt ($MM) as of last quarter is 2
BIMI International Medical Inc. ( BIMI ) Annual Working Capital Investments ($MM) are -5
BIMI International Medical Inc. ( BIMI ) Book Value ($MM) as of last quarter is 12
BIMI International Medical Inc. ( BIMI ) Debt/Capital as of last quarter is 18%
Other Balance Sheet Stats:
BIMI International Medical Inc. ( BIMI ) has 1 million in cash on hand as of last quarter
BIMI International Medical Inc. ( BIMI ) has 19 million of liabilities due within 12 months, and long term debt 0 as of last quarter
BIMI International Medical Inc. ( BIMI ) has 4 common shares outstanding as of last quarter
BIMI International Medical Inc. ( BIMI ) has 0 million USD of preferred stock value
Academic Scores:
BIMI International Medical Inc. ( BIMI ) Altman Z-Score is -2.19 as of last quarter
BIMI International Medical Inc. ( BIMI ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
BIMI International Medical Inc. ( BIMI ) largest shareholder is owning shares at 0.00 ($MM) value
(an insider) shares of BIMI International Medical Inc. ( BIMI ) for the amount of $ on
31.93% of BIMI International Medical Inc. ( BIMI ) is held by insiders, and 5.54% is held by institutions
BIMI International Medical Inc. ( BIMI ) went public on 2006-10-18
Other BIMI International Medical Inc. ( BIMI ) financial metrics:
FCF:-16.69
Unlevered Free Cash Flow:6.55
EPS:0.92
Operating Margin:23.38
Gross Profit Margin:51.89
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:38.73
Beta:2.84
Buffet's Owners Earnings:-13.00
Price to Owner's Earnings:-0.70
About BIMI International Medical Inc. ( BIMI ) :
BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes generic drugs, Chinese herbal medicine, biochemical drugs, raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers preion and over-the-counter drugs, nutritional supplements, health foods, sundry products, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is based in Chongqing, the People's Republic of China.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.